3M | GenomeWeb

3M

Bruker said the new agreement would allow it to develop the platform for use in pathology labs, including building clinically validated content libraries.

The 3M Molecular Detection Assay 2 – Listeria monocytogenes is 30 percent faster than the first-generation test.

Brainco Biopharma has been awarded

3M Food Safety said last week that its 3M Molecular Detection Assay Salmonella has received an extension of the current NF Validation certificate from ANFOR Certification.

NEW YORK (GenomeWeb News) – Bruker said today it has signed an exclusive patent license agreement with 3M Company that allows it to include in its products patented 3M technology related to MALDI mass spec imaging.

The UK's Medical Research Council has been awarded US Patent No. 8,435,775, "Mutant Pfu DNA polymerase."
Phillip Holliger, Nicola Ramsay, and Ann-Sofie Jemth are named as inventors.

UK-based molecular diagnostics developer Lumora has partnered with the Foundation for Innovative New Diagnostics to develop a rapid, high-throughput malaria diagnostic assay to screen patients in the developing world.

Evogen, a Lenexa, Kansas-based developer of molecular detection and diagnostic technologies, said this week that it has non-exclusively licensed its PCR probe technology to Focus Diagnostics, a Quest Diagnostics subsidiary.

Affymetrix said this week that it has signed an agreement with South Korea's DNA Link granting that company a worldwide license to develop and commercialize a forensic test for comprehensive human identification and other diagnostic tests using Affymetrix's micro

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.